This agrees with the previous study by Wu et al. [40], which showed that Bevacizumab blocked VEGF inhibition of TNF-α-induced expression of ICAM-1 and VCAM-1 in the melanoma-associated ECs. The gene discussed is ICAM1; the disease is melanoma.